In the BioHarmony Drug Report Database

"Preview" Icon

Lofexidine

Lucemyra (lofexidine) is a small molecule pharmaceutical. Lofexidine was first approved as Lucemyra on 2018-05-16. It is used to treat substance withdrawal syndrome in the USA. It is known to target alpha-2B adrenergic receptor, alpha-2A adrenergic receptor, and alpha-2C adrenergic receptor.

 

Trade Name

 

Lucemyra
 

Common Name

 

lofexidine
 

ChEMBL ID

 

CHEMBL17860
 

Indication

 

substance withdrawal syndrome
 

Drug Class

 

Image (chem structure or protein)

Lofexidine structure rendering